NORWOOD, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today ...
The Federal Court has upheld the denial of Canada Recovery Benefit (CRB) due to insufficient evidence and the applicant's failure to attend the hearing. In Li v. Canada (Attorney General), 2024 FC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback